At a glance
ClinicalIndex Comparison RecordPhase 3Completed· 30 enrolled
Drug / intervention
adapalene gel, 0.3% +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Comparative Study of Adapalene Gel 0.3% Versus Tretinoin 0.05% Emollient Cream, for the Treatment of Photodamage
In Brief
A Phase 3 clinical trial evaluating adapalene gel, 0.3% and tretinoin 0.05% emollient cream for Photoaging. Completed, enrolled 30 participants across 1 site.
Detailed Summary
The primary purpose of this study is to compare the efficacy of adapalene (Differin®) gel 0.3% and tretinoin 0.05% emollient cream for the treatment of signs of photodamage, with tolerability assessment as a secondary objective.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPhotoaging
CountriesUnited States
Collaborators--
Timeline
Phase 3CompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedMar 2008
Enrollment StartApr 2008
Primary CompletionJan 2010
TodayJul 2026
First PostedMar 31, 2008
Enrollment StartApr 1, 2008
Primary CompletionJan 1, 2010
TodayJul 2, 2026
Enrollment to primary: 1.8 yearsPosted 18.3 years ago
Interventions
adapalene gel, 0.3%drug
applied topically once daily in the evening
tretinoin 0.05% emollient creamdrug
applied topically once daily in the evening